Australian Clinical Labs Limited

ASX:ACL Stock Report

Mkt Cap: AU$610.5m

Australian Clinical Labs Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:ACL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Nov 22SellAU$5,138,720Regal Partners LimitedCompany1,470,015AU$3.60
09 Nov 22BuyAU$42,062,502Regal Partners LimitedCompany10,840,329AU$5.79
04 Oct 22SellAU$71,000Michael StanfordIndividual20,000AU$3.55
14 Sep 22BuyAU$6,179,026River Capital Pty Ltd.Company1,361,333AU$4.54
14 Sep 22SellAU$3,719,414River Capital Pty Ltd.Company821,868AU$4.53
09 Sep 22SellAU$139,877Leanne RoweIndividual32,500AU$4.30
01 Sep 22SellAU$26,844,699Ethical Partners Funds ManagementCompany6,272,128AU$4.28
18 Aug 22BuyAU$46,332Ethical Partners Funds ManagementCompany10,296AU$4.50
17 Aug 22BuyAU$940,064Goldman Sachs Group, Investment Banking and Securities InvestmentsCompany200,699AU$4.68
17 Aug 22SellAU$577,894Goldman Sachs Group, Investment Banking and Securities InvestmentsCompany120,530AU$4.79
15 Aug 22BuyAU$52,733,840River Capital Pty Ltd.Company11,434,849AU$4.61
12 Aug 22BuyAU$13,832,072Goldman Sachs Group, Investment Banking and Securities InvestmentsCompany2,729,715AU$5.07
11 Aug 22BuyAU$18,300,923Ethical Partners Funds ManagementCompany3,636,498AU$5.03
11 Aug 22BuyAU$9,454,801Yarra Funds Management LimitedCompany1,948,318AU$4.85
11 Aug 22SellAU$7,815,010Ethical Partners Funds ManagementCompany1,407,484AU$5.55
11 Aug 22SellAU$11,065,986Yarra Funds Management LimitedCompany2,346,747AU$4.72
07 Jul 22BuyAU$20,467Goldman Sachs Asset Management, L.P.Company4,473AU$4.58
21 Apr 22BuyAU$9,599Andrew DuttonIndividual1,897AU$5.06
21 Apr 22BuyAU$29,996Michael AlscherIndividual5,928AU$5.06
21 Apr 22BuyAU$334,972Melinda McGrathIndividual66,200AU$5.06
25 Feb 22BuyAU$36,960Michael StanfordIndividual8,000AU$4.62

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACL?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme1,023,7150.5%
Individual Insiders9,159,2994.6%
Private Companies10,008,5955.0%
General Public17,453,7708.7%
VC/PE Firms60,235,67130.0%
Institutions102,929,25051.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 87.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
30%
Crescent Capital Partners Management Pty Ltd.
60,235,671A$184.9m-13.87%54.33%
9.38%
National Australia Bank Limited, Asset Management Arm
18,842,542A$57.8m0%6.56%
7.73%
Ethical Partners Funds Management
15,525,294A$47.7m-20.62%9.47%
4.84%
Yarra Funds Management Limited
9,709,752A$29.8m-3.94%2.79%
4.74%
Hearts Trust
9,514,668A$29.2m-32.21%no data
4.71%
Regal Partners Limited
9,463,041A$29.1m0%1.5%
3.84%
River Capital Pty Ltd.
7,702,809A$23.6m0%14.86%
3.27%
BNP Paribas Securities Corp, Asset Management Arm
6,562,703A$20.1m0%0.86%
2.99%
The Vanguard Group, Inc.
6,000,005A$18.4m0.14%no data
2.91%
Morgan Stanley, Investment Banking and Brokerage Investments
5,841,216A$17.9m0%no data
2.56%
Credit Suisse, Investment Banking and Securities Investments
5,150,000A$15.8m0%0.02%
1.93%
Perpetual Corporate Trust Limited, Asset Management Arm
3,870,820A$11.9m-32.21%17.7%
1.7%
Goldman Sachs Group, Investment Banking and Securities Investments
3,411,851A$10.5m0%no data
1.46%
Melinda McGrath
2,923,331A$9.0m2.3%no data
1.04%
Roc Asia Pacific Co-Investment Fund Ii
2,084,287A$6.4m-32.21%no data
0.89%
Roc Capital Pty Limited
1,786,533A$5.5m-32.21%no data
0.64%
BlackRock, Inc.
1,279,758A$3.9m2%no data
0.59%
WisdomTree Asset Management, Inc.
1,178,113A$3.6m0%0.02%
0.54%
AllianceBernstein L.P.
1,087,225A$3.3m61.16%no data
0.51%
Australian Clinical Labs Limited, ESOP
1,023,715A$3.1m0%no data
0.42%
Tony Landgren
838,211A$2.6m0%no data
0.38%
Anthony Friedli
754,390A$2.3m0%no data
0.33%
Paul Richard
656,223A$2.0m0%no data
0.28%
James Davison
563,099A$1.7m0%no data
0.26%
Bessemer Investment Management LLC
512,824A$1.6m57.36%no data